Brandon D L Marshall1, Janet P Tate, Kathleen A McGinnis, Kendall J Bryant, Robert L Cook, E Jennifer Edelman, Julie R Gaither, Christopher W Kahler, Don Operario, David A Fiellin, Amy C Justice. 1. aDepartment of Epidemiology, Brown University School of Public Health, Providence, Rhode Island bVA Connecticut Healthcare System, West Haven cDepartment of Internal Medicine, Yale University School of Medicine dCenter for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut eNational Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland fDepartment of Epidemiology, University of Florida, Gainesville, Florida gDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut hDepartment of Behavioral and Social Sciences iCenter for Alcohol and Addiction Studies and the Alcohol Research Center on HIV (ARCH), Brown University School of Public Health, Providence, Rhode Island, USA.
Abstract
OBJECTIVE: We examined the relationship between alcohol use trajectories and HIV disease severity among men and women participating in the Veterans Aging Cohort Study (VACS). DESIGN: Prospective cohort of HIV-infected persons in care at eight US Veterans Health Administration sites. METHODS: Between 2002 and 2010, we assessed alcohol consumption annually using the alcohol use disorders identification test-consumption (AUDIT-C). HIV disease severity was ascertained using the VACS index, a validated measure of morbidity and all-cause mortality. We examined the relationship between alcohol use and HIV disease severity patterns using joint trajectory modeling. Alcohol use trajectories were validated using phosphatidylethanol - a biomarker of alcohol consumption - measured between 2005 and 2006 among a subset of participants. We examined associations between membership in alcohol use and VACS index trajectories using multinomial regression. RESULTS: Among eligible participants, we identified four alcohol consumption trajectories: abstainers (24% of the sample), lower risk (44%), moderate risk (24%), and higher risk drinkers (8%). Alcohol use trajectories were highly correlated with phosphatidylethanol (Cramér's V = 0.465, P < 0.001): mean concentrations were 4.4, 17.8, 57.7, and 167.6 ng/ml in the abstainer, lower risk, moderate risk, and higher risk groups, respectively. Four VACS index trajectories were identified: low (2%), moderate (46%), high (36%), and extreme (16%). Higher risk drinkers were most common in the extreme VACS index group, and were absent in the low index group. In multivariable analysis, the association between alcohol use and VACS index trajectory membership remained significant (P = 0.002). CONCLUSION: Alcohol use trajectories characterized by persistent unhealthy drinking are associated with more advanced HIV disease severity among HIV-infected veterans in the United States.
OBJECTIVE: We examined the relationship between alcohol use trajectories and HIV disease severity among men and women participating in the Veterans Aging Cohort Study (VACS). DESIGN: Prospective cohort of HIV-infectedpersons in care at eight US Veterans Health Administration sites. METHODS: Between 2002 and 2010, we assessed alcohol consumption annually using the alcohol use disorders identification test-consumption (AUDIT-C). HIV disease severity was ascertained using the VACS index, a validated measure of morbidity and all-cause mortality. We examined the relationship between alcohol use and HIV disease severity patterns using joint trajectory modeling. Alcohol use trajectories were validated using phosphatidylethanol - a biomarker of alcohol consumption - measured between 2005 and 2006 among a subset of participants. We examined associations between membership in alcohol use and VACS index trajectories using multinomial regression. RESULTS: Among eligible participants, we identified four alcohol consumption trajectories: abstainers (24% of the sample), lower risk (44%), moderate risk (24%), and higher risk drinkers (8%). Alcohol use trajectories were highly correlated with phosphatidylethanol (Cramér's V = 0.465, P < 0.001): mean concentrations were 4.4, 17.8, 57.7, and 167.6 ng/ml in the abstainer, lower risk, moderate risk, and higher risk groups, respectively. Four VACS index trajectories were identified: low (2%), moderate (46%), high (36%), and extreme (16%). Higher risk drinkers were most common in the extreme VACS index group, and were absent in the low index group. In multivariable analysis, the association between alcohol use and VACS index trajectory membership remained significant (P = 0.002). CONCLUSION:Alcohol use trajectories characterized by persistent unhealthy drinking are associated with more advanced HIV disease severity among HIV-infected veterans in the United States.
Authors: Amy C Justice; Elizabeth Dombrowski; Joseph Conigliaro; Shawn L Fultz; Deborah Gibson; Tamra Madenwald; Joseph Goulet; Michael Simberkoff; Adeel A Butt; David Rimland; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Sheldon Brown; David A Leaf; Matthew B Goetz; Kendall Bryant Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: Kathleen A McGinnis; David A Fiellin; Janet P Tate; Robert L Cook; R Scott Braithwaite; Kendall J Bryant; E Jennifer Edelman; Adam J Gordon; Kevin L Kraemer; Stephen A Maisto; Amy C Justice Journal: AIDS Behav Date: 2016-03
Authors: Alexander Y Walley; Debbie M Cheng; Howard Libman; David Nunes; C Robert Horsburgh; Richard Saitz; Jeffrey H Samet Journal: AIDS Date: 2008-01-30 Impact factor: 4.177
Authors: Ionut Bebu; Janet Tate; David Rimland; Octavio Mesner; Grace E Macalino; Anuradha Ganesan; Jason F Okulicz; Mary Bavaro; Amy C Weintrob; Amy C Justice; Brian K Agan Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731
Authors: Sheldon T Brown; Janet P Tate; Tassos C Kyriakides; Katherine A Kirkwood; Mark Holodniy; Joseph L Goulet; Brian J Angus; D William Cameron; Amy C Justice Journal: PLoS One Date: 2014-03-25 Impact factor: 3.240
Authors: Kevin L Kraemer; Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Adam J Gordon; Jonathan Robbins; Susan Zickmund; Kendall Bryant; P Todd Korthuis Journal: J Subst Abuse Treat Date: 2019-05-07
Authors: Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook Journal: Alcohol Clin Exp Res Date: 2017-12-05 Impact factor: 3.455
Authors: Derek D Satre; Varada Sarovar; Wendy Leyden; Charles B Hare; Sheryl L Catz; Kendall J Bryant; Emily C Williams; J Carlo Hojilla; Michael A Horberg; Michael J Silverberg Journal: AIDS Behav Date: 2020-06
Authors: Christopher T Rentsch; Janet P Tate; Tessa Steel; Adeel A Butt; Cynthia L Gibert; Laurence Huang; Margaret Pisani; Guy W Soo Hoo; Stephen Crystal; Maria C Rodriguez-Barradas; Sheldon T Brown; Matthew S Freiberg; Christopher J Graber; Joon W Kim; David Rimland; Amy C Justice; David A Fiellin; Kristina A Crothers; Kathleen M Akgün Journal: J Acquir Immune Defic Syndr Date: 2019-02-01 Impact factor: 3.731
Authors: Christopher W Kahler; David W Pantalone; Nadine R Mastroleo; Tao Liu; Gerald Bove; Bharat Ramratnam; Peter M Monti; Kenneth H Mayer Journal: J Consult Clin Psychol Date: 2018-08
Authors: Usama Bilal; Mary E McCaul; Heidi M Crane; W Christopher Mathews; Kenneth H Mayer; Elvin Geng; Sonia Napravnik; Karen L Cropsey; Michael J Mugavero; Michael S Saag; Heidi Hutton; Bryan Lau; Geetanjali Chander Journal: Alcohol Clin Exp Res Date: 2018-01-29 Impact factor: 3.455